Academic literature on the topic 'IL-10'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'IL-10.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "IL-10"
Commins, Scott, John W. Steinke, and Larry Borish. "The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29." Journal of Allergy and Clinical Immunology 121, no. 5 (May 2008): 1108–11. http://dx.doi.org/10.1016/j.jaci.2008.02.026.
Full textGlocker, Erik-Oliver, Daniel Kotlarz, Christoph Klein, Neil Shah, and Bodo Grimbacher. "IL-10 and IL-10 receptor defects in humans." Annals of the New York Academy of Sciences 1246, no. 1 (December 2011): 102–7. http://dx.doi.org/10.1111/j.1749-6632.2011.06339.x.
Full textWang, Min, Youji Hu, Ischiro Shima, and Mark E. Stearns. "IL-10/IL-10 Receptor Signaling Regulates TIMP-1 Expression." Cancer Biology & Therapy 1, no. 5 (September 13, 2002): 556–63. http://dx.doi.org/10.4161/cbt.1.5.222.
Full textRennick, Donna M., and Madeline M. Fort. "XII. IL-10-deficient (IL-10−/−) mice and intestinal inflammation." American Journal of Physiology-Gastrointestinal and Liver Physiology 278, no. 6 (June 1, 2000): G829—G833. http://dx.doi.org/10.1152/ajpgi.2000.278.6.g829.
Full textJankovic, Dragana, and Giorgio Trinchieri. "IL-10 or not IL-10: that is the question." Nature Immunology 8, no. 12 (December 2007): 1281–83. http://dx.doi.org/10.1038/ni1207-1281.
Full textMittal, Sharad K., Kyung-Jin Cho, Satoshi Ishido, and Paul A. Roche. "Interleukin 10 (IL-10)-mediated Immunosuppression." Journal of Biological Chemistry 290, no. 45 (September 25, 2015): 27158–67. http://dx.doi.org/10.1074/jbc.m115.682708.
Full textOuyang, Wenjun, and Anne O’Garra. "IL-10 Family Cytokines IL-10 and IL-22: from Basic Science to Clinical Translation." Immunity 50, no. 4 (April 2019): 871–91. http://dx.doi.org/10.1016/j.immuni.2019.03.020.
Full textConti, P., D. Kempuraj, S. Frydas, K. Kandere, W. Boucher, R. Letourneau, B. Madhappan, K. Sagimoto, S. Christodoulou, and T. C. Theoharides. "IL-10 subfamily members: IL-19, IL-20, IL-22, IL-24 and IL-26." Immunology Letters 88, no. 3 (September 2003): 171–74. http://dx.doi.org/10.1016/s0165-2478(03)00087-7.
Full textMahmood Majeed, Hameed, and Malik Hadi Qadurie. "Evaluation Relationship between IL-10, IL-1α in Hepatocellular Carcinoma Patients." Diyala Journal For Pure Science 13, no. 3 (July 1, 2017): 103–12. http://dx.doi.org/10.24237/djps.1303.252b.
Full textMurray, Henry W., Christina M. Lu, Smita Mauze, Sherry Freeman, Andre L. Moreira, Gilla Kaplan, and Robert L. Coffman. "Interleukin-10 (IL-10) in Experimental Visceral Leishmaniasis and IL-10 Receptor Blockade as Immunotherapy." Infection and Immunity 70, no. 11 (November 2002): 6284–93. http://dx.doi.org/10.1128/iai.70.11.6284-6293.2002.
Full textDissertations / Theses on the topic "IL-10"
Frisch, Kristina. "Klonierung von IL-10 und IL-10-Homologen und Funktionsanalyse in einem Mausmodell der polymikrobiellen Sepsis." [S.l.] : [s.n.], 2004. http://deposit.ddb.de/cgi-bin/dokserv?idn=973392185.
Full textNg, Tien Haeng Sky. "Mechanisms of IL-10 transcriptional regulation." Thesis, University of Bristol, 2015. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.702135.
Full textCordeiro, Cynthia Azeredo. "Polimorfismos dos Genes das Citocinas IL-1alfa, IL -1beta, IL-10 e TNF-alfa." Universidade Federal de Minas Gerais, 2008. http://hdl.handle.net/1843/RRSA-7F5KG7.
Full textWong, Li-Chuen. "IL-10 promoter polymorphisms in atopic dermatitis." Thesis, The University of Sydney, 2002. https://hdl.handle.net/2123/27849.
Full textSaramago, Eduardo Alves. "O hidrogênio molecular potencializa a hipotermia e previne a hipotensão e a febre durante a inflamação sistêmica induzida por LPS." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/17/17134/tde-07022019-140036/.
Full textMolecular hydrogen (H2) exerts anti-oxidative, anti-apoptotic, and anti-inflammatory effects. Here we tested the hypothesis that H2 modulates cardiovascular, inflammatory, and thermoregulatory changes in systemic inflammation (SI) induced by lipopolysaccharide (LPS) at different doses (0.1 or 1.5 mg/kg, intravenously, to induce mild or severe SI) in male Wistar rats (250-300 g). LPS or saline was injected immediately before the beginning of 360- minute inhalation of H2 (2% H2, 21% O2, balanced with nitrogen) or room air (21% O2, balanced with nitrogen). Deep body temperature (Tb) was measured by dataloggers preimplanted in the peritoneal cavity. H2 caused no change in cardiovascular, inflammatory parameters, and Tb of control rats (treated with saline). During mild SI, H2 reduced plasma surges of proinflammatory cytokines (TNF-? and IL-6) while caused an increase in plasma IL-10 (anti-inflammatory cytokine) and prevented fever. During severe SI, H2 potentiated hypothermia, and prevented fever and hypotension. Moreover, H2 caused a reduction in surges of proinflammatory cytokines (plasma TNF-? and IL-1?) and prostaglandin E2 [(PGE2), in plasma and hypothalamus], and an increase in plasma IL-10. These data are consistent with the notion that H2 blunts fever in mild SI, and during severe SI potentiates hypothermia, prevents hypotension and exerts anti-inflammatory effects strong enough to prevent fever by altering febrigenic signaling and ultimately down-modulating hypothalamic PGE2 production
Vale, Mariana Lima. "Atividade analgesica das interleucinas 4, 10 e 13 (IL-4, IL-10 e il-13) na dor inflamatoria experimental : papel de celulas residentes e citocinas." reponame:Repositório Institucional da UFC, 2000. http://www.repositorio.ufc.br/handle/riufc/2569.
Full textSubmitted by denise santos (denise.santos@ufc.br) on 2012-05-04T12:19:28Z No. of bitstreams: 1 2000_dis_mlvale.pdf: 664941 bytes, checksum: a8df00b6a53f2d6632ebe816657800aa (MD5)
Approved for entry into archive by Eliene Nascimento(elienegvn@hotmail.com) on 2012-05-04T12:36:24Z (GMT) No. of bitstreams: 1 2000_dis_mlvale.pdf: 664941 bytes, checksum: a8df00b6a53f2d6632ebe816657800aa (MD5)
Made available in DSpace on 2012-05-04T12:36:24Z (GMT). No. of bitstreams: 1 2000_dis_mlvale.pdf: 664941 bytes, checksum: a8df00b6a53f2d6632ebe816657800aa (MD5) Previous issue date: 2000
The release of cyclo-oxigenase products and sympathomimetics amines, the final mediators of inflammatory pain, is preceded by the generation of cytokines by resident cells. In recent years a number of cytokines such as IL-4, IL-10, IL-13, IL-6, TGF-β e IFN-α have been described to inhibit the production of TNF-α, IL-1β, IL-6 and IL-8 (cytokines regarded as pró-inflammatory) and possibly to exert their modulatory effect on macrophages and mast cells. Since it is known the capacity of those cytokines to inhibit the production of pro-inflammatory cytokines and the pivotal role of resident cells in the development of inflammatory pain we have decided to test the possibility of IL-4, IL-13 and IL-10 to modulate inflammatory pain. In short, IL-4 (1 – 5ng/animal), IL-13 (0.4 - 2.5ng/animal) or IL-10 (0.4 - 10ng/animal) was given 30 min before acetic acid (AAc) or zymosan (Zym) administration in the writhing model. IL-4 (2.5 e 5 ng/animal), IL-13 (1 e 2.5 ng/animal) or IL-10 (2 e 10 ng/animal) were injected, ip, 30 min before Zym (1 mg/animal; intra-articular) in the rat knee joint incapacitation test up to the 4th hour (the number of leukocytes was determined in the articular exsudate 6 hours later). Doses of those cytokines that exerted maximum effect in the writhing test were also injected 30 min before the hot plate test. These same doses were injected ip before naloxone administration in the AAc-induced writhing model in mice. TNF-α and IL-1β were determined in the supernatant of a macrophage culture which were collected from peritoneal fluid of mice treated with Zym and pre-treated with the cytokines under test. Our results show that interleukins 4, 13 and 10 inhibit writhing response in mice induced by AAc or Zym up to 58.7, 89.2 and 52%, and up to 62.6, 61.7 and 74.4%, respectively (p<0.05). Similar results were observed in the rat knee joint incapacitation test induced by Zym: 49.2, 56.6, 69,9% of inhibition (p<0.05). The same interleukins were able to inhibit Zym-induced leukocyte influx into articular cavity (53.8, 92.1 e 62% of inhibition, respectively - p<0,05). The analgesic activity of IL-4, IL-13 and IL-10 seems to be peripheral, since these cytokines presented no effect in the reaction time of the animals on hot plate test. This antinociceptive effect seems to have no relation with endogen opioid release since naloxone (opioid receptor antagonist) had no effect in reverting the antinociceptive effect of cytokines in the AAc-induced writhing in mice. However, IL-4 and IL-10 inhibit the release of TNF-α (42 e 41.2%, respectively - p<0.05) and of IL-1β (61.9 e 80.9%, respectively - p<0,05) by macrophages stimulated in vivo by Zym, indicating that their antinociceptive activities may be due to the inhibition of those cytokines release by resident cells.
Já está estabelecido que a liberação de produtos da cicloxigenase e aminas simpatomiméticas, mediadores finais da dor inflamatória é precedido pela geração, por células residentes, de uma cascata de citocinas. Recentemente dados do nosso laboratório demonstraram que no modelo de contorções abdominais (CA) a ativação dessa cascata é dependente também da presença de células residentes como macrófagos e mastócitos. Dados da literatura apontam algumas citocinas capazes de modular negativamente a função dessas células: IL-4,. IL-10, IL-13, IL-6, TGF-β e IFN-α . Com base nesses dados, o objetivo do presente trabalho foi estudar uma possível atividade analgésica de três citocinas: IL-4, IL-13 e IL-10. Para tanto injetou-se, via ip, IL-4 (1–5ng/animal), IL-13 (0.4-2.5ng/animal) ou IL-10 (0.4-10ng/animal) 30 min antes da administração de zymosan (Zym) ou ácido acético (AAc) para o teste de CA. IL-4 (2.5 e 5ng/animal), IL-13 (1 e 2.5ng/animal) ou IL-10 (2 e 10ng/animal) foi injetada, ip, 30 min antes do Zym (1 mg/animal; intra-articular) e logo após foi medida a incapacitação articular (IA) até a 4ª hora e na 6ª hora foi feita a contagem de leucócitos no fluido articular. As interleucinas estudadas também foram administradas (30 min antes) na dose que melhor inibiu as CA no teste da placa quente (PQ) e em camundongos que haviam recebido ou não a naloxona previamente ao estímulo (AAc) no teste de CA. IL-4 (5 ng/animal) ou IL-10 (10 ng/animal) foi injetada ip 30 min antes do Zym (ip) e após 15 min os animais foram sacrificados e o exsudato peritoneal foi colhido e posto em cultura para a dosagem de IL-1β e TNF-α no sobrenadante. No presente trabalho ficou demonstrado que as interleucinas-4, 13 e 10 são analgésicas tanto no modelo de CA induzidas por AAc (58.7, 89.2, 52% de inibição, efeito máximo, respectivamente, p<0.05) ou Zym (62.6, 61.7, 74.4% de inibição, efeito máximo, respectivamente, p<0.05) como também no modelo de IA induzido por Zym (49.2, 56.6, 69,9% de inibição, efeito máximo, respectivamente, p<0.05). As citocinas estudadas foram capazes de inibir o influxo de leucócitos para a cavidade articular (53.8, 92.1 e 62%, respectivamente - p<0,05). Foi demonstrado que o efeito analgésico parece ser de domínio periférico visto que nenhuma das citocinas modificou o tempo de reação na PQ, teste algesimétrico sensível apenas para drogas que exercem efeito central. Também foi demonstrado que a atividade analgésica das interleucinas testadas não depende da liberação de opióides endógenos, visto que o pré-tratamento com naloxona não foi capaz de reverter a atividade analgésica de nenhuma das interleucinas no modelo de CA. Contudo essa atividade analgésica parece depender da inibição da liberação de citocinas por células residentes visto que IL-4 e IL-10 foram capazes de diminuir a liberação de TNF-α (42 e 41.2% de inibição respectivamente - p<0.05) e IL-1β (61.9 e 80.9% de inibição respectivamente - p<0,05) por macrófagos peritoneais residentes.
Costa, Tânia Alves da. "A função da IL-10 na paracoccidioidomise pulmonar murina." Universidade de São Paulo, 2010. http://www.teses.usp.br/teses/disponiveis/42/42133/tde-16122010-113911/.
Full textCellular immunity is the main defense mechanism of hosts infected by the Paracoccidioide brasiliensis (Pb), a dimorphic fungus that causes the most important systemic mycosis in Latin America. IFN-g activated macrophages participate in this activity that is antagonized by IL-10 an anti-inflammatory cytokine. Both, in the human pathology and in experimental models, there are a number of evidences indicating that IL-10 acts as a suppressor of cellular immunity leading to deleterious effects to the hosts. However, direct studies aimed at investigating the function of IL-10 in the immunity to paracoccidioidomycosis (PCM) have not been performed. Thus, the fundamental objective of this work was to study the function of IL-10 in the mechanisms of innate and adaptive immunity against Pb using as experimental model IL-10 deficient mice (IL-10 Knockout, IL-10 KO) compared to their respective wild type (WT) controls. We demonstrated in vitro that normal peritoneal macrophages of IL-10 KO mice presented increased phagocytic and microbicidal activities than macrophages of WT mice and this was associated witch an elevated production of IFN-g, TNF-α, nitric oxide (NO) and the chemokine MCP-1. However, the production of IFN-g seen to be performed by NTK cells contaminating adherent macrophages, suggesting a possible participation of these cells in the activation of macrophages and T cells of IL-10 KO mice. In vivo studies revealed that at the second week of infection IL-10 KO mice presented an earlier immune response when compared to wild-type mice, since their lungs exhibited a significantly reduced fungal burden and an increased production of almost all antibodies isotypes (IgM, IgG1, IgGM, IgG2b). This effect was accompanied by a total absence of IL-4 and IL-5, showing a regulatory action of IL-10 in the synthesis of Th2 cytokines. Four weeks post-infection, the fungal load was still lower in the IL-10 KO mice but no differences in antibody synthesis was observed. However, the analysis of lung infiltrating leukocytes revealed an increased frequency of TCD4+ and TCD4+CD44 high lymphocytes in IL-10 KO mice, again demonstrating an early activation of cellular immunity in IL-10 KO mice. When compared with WT mice, the pulmonary fungal loads of IL-10 KO mice at week 8 of infection were drastically reduced and no dissemination to other organs were observed. The histopathological analysis revealed an absence of granulomas and fungi in the lungs of IL-10 KO in comparison with WT mice. The analysis of lung infiltrating leukocytes showed that IL-10 KO mice had a reduction in the frequency of B cells, in agreement with the reduced synthesis of immunoglobulins. An increased frequency of activated T CD4+ and a drastic increase of TCD4+ and T CD8+ effector/memory cells charactering once again an efficient immune response associated with IL-10 deficiency. In later stages, sixteen weeks after infection, a regressive infection of IL-10 KO mice was further characterized by low numbers of fungi in the lung, reduced synthesis of cytokines (IL-4 and IL-5) and anti- P. brasiliensis antibodies. By week 23 after infection, in addition to the characteristic reduction of fungal loads and reduced frequency of immune cells, we observed a decrease in the frequency of Treg cells, demonstrating the implication of IL-10 in the control of this T cell population. The elevated survival (90%) of IL-10 KO mice was in total agreement with the low fungal burdens and efficient immune response observed during infection. In conclusion, our work demonstrates for the first time that IL-10 plays a major role in the control of innate and adaptive immunity to Pb infection.
Cirocco, Robert E. "Cytokine analisys in atlantic bottlenose dolphins: molecular characterization of IL-4, IL-6, and IL-10." FIU Digital Commons, 2001. http://digitalcommons.fiu.edu/etd/2370.
Full textMitchell, Ruth Elizabeth. "Regulation of IL-10 in CD4+ T cells." Thesis, University of Bristol, 2015. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.691167.
Full textOLIVEIRA, Gabriela Almeida de. "Polimorfismos de citocinas (TNF-A, IL-10 e IL-17) no câncer gástrico." Universidade Federal do Pará, 2016. http://repositorio.ufpa.br/jspui/handle/2011/7251.
Full textApproved for entry into archive by Edisangela Bastos (edisangela@ufpa.br) on 2017-01-09T17:13:32Z (GMT) No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertacao_PoliformismosCitocinasCancer.pdf: 4538726 bytes, checksum: a9402888128957139063bdb3b7fd849e (MD5)
Made available in DSpace on 2017-01-09T17:13:32Z (GMT). No. of bitstreams: 2 license_rdf: 0 bytes, checksum: d41d8cd98f00b204e9800998ecf8427e (MD5) Dissertacao_PoliformismosCitocinasCancer.pdf: 4538726 bytes, checksum: a9402888128957139063bdb3b7fd849e (MD5) Previous issue date: 2016-02-02
FADESP - Fundação de Amparo e Desenvolvimento da Pesquisa
No Norte do Brasil, o câncer gástrico (GC) é a segunda neoplasia mais frequente entre os homens e o terceiro nas mulheres, portanto, um importante problema de saúde pública. A investigação de fatores genéticos relacionados com características imunológicas pode auxiliar o entendimento da carcinogênese no CG. O objetivo do presente trabalho foi polimorfismos presentes nos genes das interleucinas IL17G-197A, IL 17FA7488G, TNFαG-308A, IL10G- 1082A, IL10C-819T e IL10C-592A, em amostras de pacientes com câncer gástrico e sem câncer. O grupo caso foi composto por 100 pacientes diagnosticados com CG, atendidos no Hospital HUJBB (Pará, Brasil). O grupo controle foi constituído de 100 indivíduos, não aparentados, sem câncer da mesma população. O material genético foi extraído a partir de 5 mL de sangue periférico pelo kit comercial de DNA da Roche, seguido de quantificação com o NanoDrop 1000 spectrophotometer. Molecular analysis of the polymorphisms was performed by real-time PCR with TaqMan® probes. E as medidas de ancestralidade foram investigadas utilizando um painel de 48 marcadores autossômicos informativos de ancestralidade (AIMs). As proporções de ancestralidade de Europeu, Africano e Ameríndio foram estimadas usando o software STRUCTURE v.2.3.3. Como resultado, observou-se que a composição étnica do grupo com câncer foi de 27% africano, 42% europeu, e 31% de ameríndia. No grupo sem câncer, a composição foi de 21 % africano, 52% europeia, e 27% de ameríndia. Em relação ao conjunto de marcadores da interleucina IL-10 (IL10G-1082A, IL10C-819T, IL10C-592A), quando comparados os padrões genotípicos e haplotípicos observou-se que a distribuição haplotípica, quando relacionada a elevada expressão (GCC/GCC, GCC/GCA, GCC/GTC, GCA/GCA, GCA/GTA) foi mais frequente no grupo de pacientes com câncer gástrico (p=1,15E-11; OR=2,630; IC 95%=2,116-3,271). Em indivíduos que possuíam o genótipo relacionado com a elevada produção de IL-10, detectou-se maior frequência da ancestralidade europeia no grupo de indivíduos controle (p=1E-06), enquanto no grupo de pacientes com CG observou significante frequência da ancestralidade africana (p=1.4 e-5), pacientes que apresentaram genótipos TNF-α AA e TNF-α AG para mutação no gene TNF-α, apresentam risco elevado para desenvolvimento do câncer (P <000.1; OR 10.375; IC 95% 3.149- 34.061). Concluimos que a distribuição haplotípica dos marcadores da interleucina IL-10 (IL10G-1082A, IL10C-819T, IL10C-592A) quando relacionados a elevada expressão e predominância de ancestralidade africana, possuem maior risco de desenvolvimento do CG.
Gastric cancer (GC) is the second most common malignancy among men and the third in women, and therefore, an important public health problem in northern Brazil. The investigation of genetic factors related to immunological characteristics can aid the understanding of carcinogenesis in CG. The objective of the present work was investigate polymorphisms present in interleukin genes IL17G-197A, IL 17FA7488G, TNFαG-308A, IL10G-1082A, IL10C-819T e IL10C-592A, on samples of patients with gastric cancer and healthy patients without cancer. Case group was composed of 100 patients diagnosed with CG, met in the Hospital HUJBB (Pará, Brazil). Control group was composed of 100 individuals without cancer, unrelated, of the same population. The genetic material was extracted from 5 mL of peripheral blood with the DNA commercial kit from Roche, followed by quantification with the NanoDrop 1000 spectrophotometer. Analysis of the molecular polymorphisms was performed by real-time PCR with Taqman® probes. Measures of ancestry were investigated using a panel of 48 autosomal ancestry informative markers (AIMs). The proportions of ancestry of European, African and Amerindian were estimated using the software STRUCTURE v. 2.3.3. It was observed that the ethnic composition of the case group was 27% African, 42% European and 31% of Amerindian, while in the control group 21% African, 52% of European and 27% of Amerindian. In relation to the set of markers of interleukin IL-10 (IL10G-1082A, IL10C-819T, IL10C-592A), when the genotypic and haplotypic patterns were compared, it was noted that the haplotype distribution related to high expression (GCC/GCC, GCA, GCC/GCC/GTC, GCA/GCA, GCA/GTA) was more frequent in the patients with gastric cancer (P = 1,15e-11; OR = 2.630; IC 95% = 2.116-3.271). Among the individuals with the genotype related to the high production of IL-10, it was observed that the control group had more European contribution in their ancestry (P = 1e-06) while the group of patients with CG had more African contribution in their ancestry (P = 1.4e-5). Patients who presented TNF-α AA and TNF-α AG genotypes for TNF-α gene mutation presented a higher risk for development of cancer (P<0.001; OR 10.375; IC 95% 3.149-34.061). It is concluded that patients with a distribution of haplotypic markers of interleukin IL-10 (IL10G-1082A, IL10C-819T, IL10C-592A) related to a higher expression and higher contribution of African ancestry have a high risk of developing gastric cancer.
Books on the topic "IL-10"
Grossi, Plinio. Il Ticino dei '10. Pregassona: Fontana, 1997.
Find full textGordon, Yefim. Ilyushin IL-2 and IL-10 Shturmovik. Ramsbury: Crowood, 2004.
Find full textCosta, Manuel Rui. Il mio 10 per Firenze. [Italy]: AN.MA & San Marco Sport Events, 1998.
Find full textMübariz, Qurbanlı, and Ălii̐ev Ilgar, eds. Yeni Azärbaycan Partiyası 10 il. Bakı: Azarbaycan, 2002.
Find full textCastel nuovo (Museum : Naples, Italy), ed. Il Futurismo: Anni '10 - anni '20. Milano: Skira, 2018.
Find full textChiara, Piero. Il Decameron raccontato in 10 novelle. Milano: A. Mondadori, 1992.
Find full textPaek, Tʻae-wŏn. Paek Tʻae-wŏn kongye chakpʻumjŏn: 1985-yŏn 10-wŏl 10-il--16-il Tongbang Pʻŭllaja Misulgwan. [Seoul]: Kabŭl, 1985.
Find full textKim, Chŏng-il. Misullon: 1991-yŏn 10-wŏl 16-il. [Pʻyŏngyang]: Chosŏn Nodongdang Chʻulpʻansa, 1992.
Find full textKim, Chŏng-il. Misullon: 1991-yŏn 10-wŏl 16-il. [Pʻyŏngyang]: Chosŏn Nodongdang Chʻulpʻansa, 1992.
Find full textHanʼgŭl mit Hanʼgugŏ Chŏngbo Chʻŏri Haksul Taehoe (4th 1992 Hanʼguk Tʻongsin Yŏnʼgu Sentʻŏ). Inʼgan kwa kigye wa ŏnŏ: Ilsi 1992-yŏn 10-wŏl 9-il - 10-il, changso Hanʼguk Tʻongsin Yŏnʼgu Sentʻŏ. Sŏul-si: Hanʼguk Chŏngbo Kwahakhoe, 1992.
Find full textBook chapters on the topic "IL-10"
Benjamin, David. "Interleukin-10 (IL-10)." In Cytokines: Interleukins and Their Receptors, 305–19. Boston, MA: Springer US, 1995. http://dx.doi.org/10.1007/978-1-4613-1241-3_12.
Full textEngelhardt, Karin R., and Bodo Grimbacher. "IL-10 in Humans: Lessons from the Gut, IL-10/IL-10 Receptor Deficiencies, and IL-10 Polymorphisms." In Current Topics in Microbiology and Immunology, 1–18. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-43492-5_1.
Full textLee, Myung-Shik, and Nora Sarvetnick. "IL-10 Transgenic Mice." In Interleukin-10, 135–39. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-662-22038-2_15.
Full textShanmugam, Saravanan, Jullyana S. S. Quintans, Parimelazhagan Thangaraj, Luciana Scotti, Marcus T. Scotti, Adriano A. S. Araújo, and Lucindo J. Quintans-Júnior. "Monoterpenes Modulating IL-10." In Phytomedicine, 157–68. First edition. | Boca Raton, FL : CRC Press, 2020.: CRC Press, 2020. http://dx.doi.org/10.1201/9781003014898-16.
Full textCarvalho, Edgar M. "IL-10 In Human Leishmaniasis." In Interleukin-10, 91–100. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-662-22038-2_10.
Full textSieling, Peter A., and Robert L. Modlin. "IL-10 in Mycobacterial Infection." In Interleukin-10, 79–89. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-662-22038-2_9.
Full textSchroeder, John T. "Diagnostic Components: T Helper Cell Cytokines (IL-4, IL-5, IL-9, IL-10, IL-13, IL-17)." In Encyclopedia of Medical Immunology, 221–26. New York, NY: Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-9194-1_298.
Full textSchuitemaker, Hanneke, Neeltje A. Kootstra, and Frank Miedema. "IL-10 and HIV-1 Replication." In Interleukin-10, 101–12. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-662-22038-2_11.
Full textYssel, Hans, and René de Waal Malefyt. "IL-10 and Human T Cells." In Interleukin-10, 19–27. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-662-22038-2_3.
Full textVan Vlasselaer, Peter. "IL-10 and Bone Formation/Hematopoiesis." In Interleukin-10, 59–67. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-662-22038-2_7.
Full textConference papers on the topic "IL-10"
Darmaputra, I. Gusti Nyoman, Luh Mas Rusyati, Wibi Riawan, Anang Endaryanto, and Cita Rosita Sigit Prakoeswa. "The Correlation between Neutrophil CD64, Interleukin-17 (Il-17), Interleukin-10 (Il-10) in Skin Tissue and Neutrophil CD64, Il-17 and Il-10 in Blood Circulation in Erythema Nodosum Leprosum (ENL) Patients." In The 23rd Regional Conference of Dermatology 2018. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008155802860290.
Full textKhan, Aslam A. "Abstract 387: PEDF binds to IL- 10 receptor in the absence of IL-10 and inhibits melanoma tumor growth." In Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-387.
Full textGollnick, Sandra O., David A. Musser, and Barbara W. Henderson. "Photodynamic therapy affects the expression of IL-6 and IL-10 in vivo." In BiOS '98 International Biomedical Optics Symposium, edited by Steven L. Jacques. SPIE, 1998. http://dx.doi.org/10.1117/12.308168.
Full textCerri, S., M. Gold, J. Jin, T. Robinson, S. Thompson, S. Smyk-Pearson, DA Lewinsohn, and DM Lewinsohn. "Human IL-10 Producing T Cells Specific forMycobacterium tuberculosis." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a5907.
Full textSenturk, T., BG Cetin, and N. Aydin. "315 The relationship between il-10, il-17, il-23 and vitamin d levels, and disease activity of systemic lupus erythematosus." In LUPUS 2017 & ACA 2017, (12th International Congress on SLE &, 7th Asian Congress on Autoimmunity). Lupus Foundation of America, 2017. http://dx.doi.org/10.1136/lupus-2017-000215.315.
Full textSato, K., Y. Aizaki, H. Yazawa, and T. Mimura. "AB0066 Combination of il-10 and il-18 but not il-6 and il-18 induces ifn-gamma production and surface expression of trail on nk cells." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.3407.
Full textCai, J., G. Su, X. Qi, A. Emtiazjoo, P. A. Efron, M. Brantly, B. Mehrad, et al. "Myeloid-Derived Suppressor Cells Ameliorate Lung Ischemia-Reperfusion Injury Via Regulation of IL-17 and IL-10." In American Thoracic Society 2020 International Conference, May 15-20, 2020 - Philadelphia, PA. American Thoracic Society, 2020. http://dx.doi.org/10.1164/ajrccm-conference.2020.201.1_meetingabstracts.a1002.
Full textOrellana, C., R. Sanmartí, JD Cañete, J. Yagüe, G. Ercilla, A. Gómez, G. Salvador, and J. Muñoz-Gómez. "THU0002 Il-10 and il-6 polymorphisms are not related to erosive disease in early rheumatoid arthritis." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.105.
Full textRadbruch, AH, M. Loehning, A. Richter, T. Stamm, O. Soezeri, HD Chang, L. Tykocinski, and M. Assenmacher. "THU0051 Proliferation and stability of cytokine expression of il-4 or il-10 secreting t helper cells." In Annual European Congress of Rheumatology, Annals of the rheumatic diseases ARD July 2001. BMJ Publishing Group Ltd and European League Against Rheumatism, 2001. http://dx.doi.org/10.1136/annrheumdis-2001.848.
Full textTerai, Mizue, Masumi Eto, Garbo D. Young, Michael J. Mastrangelo, Yutaka Tamura, Kenichi Harigaya, and Takami Sato. "Abstract 1913: Proinflammatory cytokine, Interleukin-6 (IL-6), promotes Interleukin-10 (IL-10) production from melanoma cell via JAK/STAT3 and Raf/ERK signal pathways." In Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1538-7445.am10-1913.
Full textReports on the topic "IL-10"
Petkova, Boryana, Emilia Alova, Iliya Karagyozov, Polya Stoyanova, Vladimir Jekov, Milena Mourdjeva, and Tsvetelina Oreshkova. IL-10: a Potential Prognostic Biomarker for Missed Abortion. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, July 2019. http://dx.doi.org/10.7546/crabs.2019.07.16.
Full textCao, Xianling, Xuanyou Zhou, Naixin Xu, Songchang Chang, and Chenming Xu. Association of IL-4 and IL-10 Polymorphisms with Preterm Birth Susceptibility: A Systematic Review and Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0044.
Full textGrigorov, Boncho G., Anastasiya G. Trenova, Georgi S. Slavov, Lyuba D. Miteva, and Spaska A. Stanilova. Interleukin‑10 (IL‑10) Promoter Polymorphism at Position –1082 in Bulgarian Patients with Multiple Sclerosis. "Prof. Marin Drinov" Publishing House of Bulgarian Academy of Sciences, February 2019. http://dx.doi.org/10.7546/crabs.2019.01.11.
Full textJafrin, Sarah, Md Abdul Aziz, and Mohammad Safiqul Islam. Elevated levels of pleiotropic interleukin-6 (IL-6) and interleukin-10 (IL-10) are critically involved with the severity and mortality of COVID-19: An updated longitudinal meta-analysis and systematic review on 147 studies. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0046.
Full textSplitter, Gary, Zeev Trainin, and Yacov Brenner. Lymphocyte Response to Genetically Engineered Bovine Leukemia Virus Proteins in Persistently Lymphocytic Cattle from Israel and the U.S. United States Department of Agriculture, July 1995. http://dx.doi.org/10.32747/1995.7570556.bard.
Full textTillett, Will, and Oliver Jones. Améliorer l’assainissement rural dans les contextes difficiles. The Sanitation Learning Hub, Institute of Development Studies, March 2021. http://dx.doi.org/10.19088/slh.2021.021.
Full textLi, Zifeng, Yuling Fan, Yunhong Lei, Xiaoqiang Hou, and Caiyun Chang. A protocol for systematic review and network meta-analysis Efficacy and Safety of Kunxian Capsule in Treating Patients with Lupus Nephritis:A network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, December 2021. http://dx.doi.org/10.37766/inplasy2021.12.0005.
Full textLiu, Miao, Hongan Wang, Jing Lu, Zhiyue Zhu, Chaoqun Song, Ye Tian, Xinzhi Chen, et al. Vitamin D supplementation in the treatment of Myasthenia Gravis A protocol for a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, September 2022. http://dx.doi.org/10.37766/inplasy2022.9.0129.
Full textRipoll, Santiago, Tabitha Hrynick, Ashley Ouvrier, Megan Schmidt-Sane, Federico Marco Federici, and Elizabeth Storer. 10 façons dont les gouvernements locaux en milieu urbain multiculturel peuvent appuyer l’égalité vaccinale en cas de pandémie. SSHAP, January 2023. http://dx.doi.org/10.19088/sshap.2023.001.
Full textHovav, Ran, Peggy Ozias-Akins, and Scott A. Jackson. The genetics of pod-filling in peanut under water-limiting conditions. United States Department of Agriculture, January 2012. http://dx.doi.org/10.32747/2012.7597923.bard.
Full text